|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:GPCPD1-CASC20 (FusionGDB2 ID:HG56261TG101929244) |
Fusion Gene Summary for GPCPD1-CASC20 |
Fusion gene summary |
Fusion gene information | Fusion gene name: GPCPD1-CASC20 | Fusion gene ID: hg56261tg101929244 | Hgene | Tgene | Gene symbol | GPCPD1 | CASC20 | Gene ID | 56261 | 101929244 |
Gene name | glycerophosphocholine phosphodiesterase 1 | cancer susceptibility 20 | |
Synonyms | EDI3|GDE5|GDPD6|PREI4 | - | |
Cytomap | ('GPCPD1')('CASC20') 20p12.3 | 20p12.3 | |
Type of gene | protein-coding | ncRNA | |
Description | glycerophosphocholine phosphodiesterase GPCPD1endometrial differential 3glycerophosphocholine phosphodiesterase GDE1 homologglycerophosphodiester phosphodiesterase 5preimplantation protein 4putative glycerophosphocholine phosphodiesterase GPCPD1puta | cancer susceptibility 20 (non-protein coding)cancer susceptibility candidate 20 (non-protein coding) | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | |||
Fusion gene scores | * DoF score | 6 X 6 X 3=108 | 0 X 0 X 0=0 |
# samples | 6 | 0 | |
** MAII score |